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Reference values for leptin and adiponectin in children below
the age of 10 based on the IDEFICS cohort
E Erhardt1,10, R Foraita2,10, I Pigeot2,3, G Barba4, T Veidebaum5, M Tornaritis6, N Michels7, G Eiben8, W Ahrens2,3, LA Moreno9,
E Kovács1 and D Molnár1 on behalf of the IDEFICS consortium
OBJECTIVE: To establish age- and sex-speciﬁc reference values for serum leptin and adiponectin in normal-weight 3.0–8.9-year
old European children.
SUBJECTS AND METHODS: Blood samples for hormone analysis were taken from 1338 children of the IDEFICS (Identiﬁcation and
prevention of Dietary- and lifestyle-induced health Effects in Children and infantS) study cohort. Only normal-weight children aged
3.0–8.9 years were included (n= 539) in our analysis. Using the General Additive Model for Location Scale and Shape, age- and
sex-speciﬁc percentiles were derived. The inﬂuence of under/overweight and obesity on the proposed reference curves based on
normal-weight children was investigated in several sensitivity analyses using the sample without obese children (n= 1015) and
the whole study sample (n= 1338).
RESULTS: There was a negative age trend of adiponectin blood levels and a positive trend of leptin levels in boys and girls.
Percentiles derived for girls were generally higher than those obtained for boys. The corresponding age-speciﬁc differences of the
97th percentile ranged from − 2.2 to 4.6 μgml− 1 and from 2.2 to 4.8 ngml− 1 for adiponectin and leptin, respectively.
CONCLUSIONS: According to our knowledge, these are the ﬁrst reference values of leptin and adiponectin in prepubertal,
normal-weight children. The presented adiponectin and leptin reference curves may allow for a more differentiated interpretation
of children’s hormone levels in epidemiological and clinical studies.
International Journal of Obesity (2014) 38, S32–S38; doi:10.1038/ijo.2014.133
INTRODUCTION
Adipose tissue secretes a number of biologically active adipokines,
which are low-molecular weight peptides. These peptides have
numerous central and peripheral functions and have an important
role in fat- and whole-body metabolism.1 Leptin and adiponectin
have endocrine and metabolic functions. Leptin was the ﬁrst
identiﬁed adipocytokine secreted mainly in white adipose tissue,
but it has also been detected in many other tissues including
placenta, endometrium and in gastrointestinal tracts. Leptin
contributes to body weight regulation through modulating
feeding as a satiety signal and stimulates energy expenditure.2,3
Serum leptin concentrations are increased in obese male and
females compared with non-obese individuals. A distinct dimorph-
ism can be found between boys and girls especially during
progressive pubertal stages. Matsubara et al.,4 who investigated
only obese women, reported that serum leptin concentrations are
increased as a consequence of ‘leptin resistance’. Levels of leptin
are related to body fat mass and fat distribution, and they change
during puberty.5 According to recent ﬁndings, leptin may be a link
between obesity and metabolic disorders.6 It is known that leptin
deﬁciency leads to obesity, but also to diabetes and to
reproductive dysfunction. Leptin also has a role in immune
response; it modulates the monocytes and macrophages, natural
killers and dendritic cells.
Adiponectin is one of the most abundant plasma proteins
produced in white adipose tissue. Plasma adiponectin concentra-
tions were found to be decreased in obese patients, in the case
of type 2 diabetes mellitus, insulin resistance and dyslipidaemia
and it is known to be a marker of the metabolic syndrome.6,7
Pubertal development can inﬂuence serum adiponectin levels, as
indicated by the observed difference between sexes during early
adulthood.2,7
According to a literature review, normative values of leptin and
adiponectin for children are mainly based on small national study
populations.8–11 European reference standards from unselected
populations are missing. Therefore, the main objective of this
paper is to establish age- and sex-speciﬁc reference values for
leptin and adiponectin, based on a European sample of normal-
weight children aged 3.0–8.9 years from eight European countries
who participated in the baseline examinations of the IDEFICS
(Identiﬁcation and prevention of Dietary- and lifestyle-induced
health Effects in Children and infantS) study.
SUBJECTS AND METHODS
Study subjects
A cohort of 16 228 children aged 2–9 years was examined in a population-
based baseline survey in eight European countries ranging from North to
South and from East to West (Sweden, Germany, Hungary, Italy, Cyprus,
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Spain, Belgium, Estonia) from autumn 2007 to spring 2008. The study was
not designed to provide a representative sample for each country. Rather,
this baseline survey was the starting point of a prospective cohort study
with the largest European children’s cohort established to date. Additional
2517 new children were included in the follow-up survey (2009–2010).
All children in the deﬁned age group who resided in the deﬁned regions
and who attended the selected primary schools (grades 1 and 2),
preschools or kindergartens were eligible for participation. Children were
approached via schools and kindergartens to facilitate equal enrolment of
all social groups. All study centres obtained ethical approval from their
local Ethics Committees. In addition to the signed informed consent given
by parents, each child was asked to give verbal assent immediately before
examination. Participants were free to opt out of speciﬁc modules like
blood drawing. The study design has been described elsewhere.12
Inclusion and exclusion criteria for the analysis group
Hormones were measured in a subsample of IDEFICS children from the
baseline survey selected for a nested case–control study on overweight
and obesity. All children exceeding the 85th percentile of age- and sex-
speciﬁc body mass index (BMI) of the IDEFICS cohort were eligible as cases.
These comprise all children classiﬁed as obese according to the IOTF
criteria13 and a sample of children in the upper range of the overweight
category. Controls were selected at random from the remaining children,
individually matched to cases by age (±0.5 years of age), sex and study
centre. To qualify for inclusion in the case–control study, the parental
questionnaires, the 24-h dietary recall and several anthropometric
measurements had to be available for each child. This restriction resulted
in 1328 case–control pairs providing these required measurements and
fasting blood. Together with a few additional children, 1338 children aged
2.0–9.9 years provided hormone measurements from fasting blood
samples. Of these, 60 children were excluded due to small numbers of
children younger than 3.0 years and older than 8.9 years. Seven hundred
and thirty-nine children were not classiﬁed as normal weight according to
Cole and Lobstein14 and were excluded because body fat is associated
with hormone levels, thus leaving 539 children for analysis (see Figure 1).
The log-transformed hormone measurements contained no outliers
(deﬁned as values outside the range of mean ±4 s.d.).
Blood hormone sampling
Fasting venous blood was collected from all children consenting to
provide biological material. Serum total leptin and adiponectin were only
measured in children selected for the case–control study. Serum samples
were frozen (−80 °C) and shipped to a central laboratory on dry ice (The
Laboratoriumsmedizin Dortmund Dr Eberhard und Partner GbR is
accredited according to DIN EN ISO 15 189 by the German Accreditation
Council). Concentration of serum leptin (ngml− 1) was measured using the
MEDIAGNOST (Reutlingen, Germany) enzyme immunoassay. The measur-
able range for leptin was 0.5–64 ngml− 1. The sensitivity of the leptin assay
was less than 0.1 ngml− 1. Adiponectin was measured by enzyme-linked
immunosorbent assay using the MEDIAGNOST (Reutlingen, Germany) kit.
The sensitivity of the adiponectin assay was less than 0.6 μgml− 1, whereas
the measurable range was 2–100 μgml− 1.
Statistical methods
We calculated percentile curves of adiponectin and leptin as a function of
age as a continuous variable, stratiﬁed by sex using the General Additive
Model for Location Scale and Shape (GAMLSS).15 The GAMLSS method is
an extension of the LMS method16 that models three parameters: the
median (M) models the outcome variable depending on one explanatory
variable, and the coefﬁcient of variation (S) accounts for the variation
around the mean and adjusts for non-uniform dispersion, whereas
the skewness parameter (L) accounts for the deviation from a normal
distribution using a Box–Cox transformation. The GAMLSS method is able
to additionally model the kurtosis using other distributions and to include
more than one covariate. We used the gamlss package (version 4.2–6)17 of
the statistical software R (version 3.0.1). Different distributions, that is, the
Box–Cox Cole and Green, gamma or inverse Gaussian distribution were
ﬁtted to the observed distribution of adiponectin and leptin. Moreover, the
inﬂuence of age on parameters of the considered distributions were
modelled either as a constant, as a linear function or as a penalised spline
of the covariate. Goodness of ﬁt was assessed by the Bayesian Information
Criterion, Q–Q plots and the sample percentages below each centile curve
to select the ﬁnal model including the ﬁtted distribution of adiponectin
and leptin and the inﬂuence of age on distribution parameters. Worm plots
were used as a diagnostic tool to assess whether adjustment for kurtosis
was required.18 Finally, percentile curves for the 1st, 3rd, 10th, 25th, 50th,
Basic study
population
N=18 745
Analysis group
N=539
60 excluded because of unsufficient sample
size of children <3.0 and ≥ 9.0 years
739 excluded because classified as
underweight,overweight or obese
Baseline survey
(2007-2008)
N=16 228
Follow-up
(2009-2010)
N=2 517
Hormone
analysis
N=1 322
Hormone
analysis
N=16
N=1 338
16 085 excluded because of
missing measurements
1 322 excluded because of 
missing measurements
Included in
obesity case-
control study
N=2 644
Not included in
obesity case-
control study
N=16 101
Figure 1. Flow chart showing the selection of the analysis group.
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75th, 90th, 97th and 99th percentiles were calculated based on the model
that showed the best goodness of ﬁt.
The ﬁnal model for leptin is based on an inverse gamma distribution for
girls, modelling log(μ), log(σ) and ν as constant. For boys, a Box–Cox power
exponential distribution was used, modelling log(μ) as penalised beta
spline depending on age, log(σ) as linear function of age, and ν and τ as
constant. With regard to adiponectin, a gamma distribution was ﬁtted for
boys and girls considering log(μ) as linear function of age and log(σ) as
linear function of age for girls and as constant for boys.
In further sensitivity analyses, we investigated the inﬂuence of fat on
leptin and adiponectin concentrations by comparing our analysis group of
normal-weight children with the whole sample of children between 2.0
and 9.9 years who provided hormone measurements (n= 1338, ngirls = 687,
nboys = 651) and with the sample only excluding the obese children
(n =1015, ngirls = 531, nboys = 484) regarding the 3th, 50th and 97th
percentile curves. For all of the sensitivity analyses except one, we used the
same distributions as for the main analysis. The analysis of leptin in boys
for the whole study sample was conducted using a generalised inverse
gamma distribution, modelling log(μ) and ν as a function of age and log(σ)
as constant.
RESULTS
Basic characteristics of the study population are presented as
mean values (± s.d.) or median (interquartile range) by 1-year age
groups in Table 1. The analysis group consists of 283 girls and 256
boys. The BMI is similar in boys and girls, but body fat mass as well
as adiponectin and leptin levels generally show a trend for higher
values in girls than in boys.
Percentiles of adiponectin and leptin are presented in 1-year
age groups in Table 2, Figures 2 and 3, respectively. Adiponectin
values are higher in girls than in boys aged 5.0 years and older.
Across all age groups, the difference between girls and boys
ranges from −2.2 to 4.6 μgml− 1 for the 97th percentile of
adiponectin. There is a negative age trend of the mean
adiponectin concentrations in both sexes, whereas there is a
positive age trend of the variance of adiponectin in girls and a
negative trend in boys.
Leptin values are generally higher in girls than in boys. Across
all age groups, the difference between boys and girls ranges from
2.2 to 4.8 ngml− 1 for the 97th percentile of leptin. Leptin
concentrations show a positive nonlinear trend with age above
the 50th percentiles and a rather constant trend up to the 50th
percentile. There is also a positive age trend for the variance of
leptin values in both sexes.
Sensitivity analyses are presented in Figures 4 and 5 comparing
percentiles for children of different BMI categories. Percentile
values for adiponectin levels show minor differences for boys of
the whole study sample as compared with the values for normal-
weight boys. The differences are more pronounced for girls: the
inclusion of obese girls pushes the percentile curves downwards.
The characteristics of the leptin curves change distinctly with the
inclusion of under/overweight and obese children. The percentile
curves are dramatically shifted upwards for the whole sample with
age in both sexes. Smaller deviations from the normal-weight
percentiles can already be detected for the 10th percentile for
girls older than 7 years and boys older than 8 years. Leptin values
are generally higher in girls than in boys for all BMI categories.
DISCUSSION
This study presents reference values of leptin and adiponectin in
mostly prepubertal, normal-weight children. Although these
reference percentiles are based on a small subgroup of the
IDEFICS cohort, only, this is the ﬁrst time that reference values of
leptin and adiponectin are proposed based on a multinational
non-clinical population.
We restricted our analysis group to normal-weight children as
especially leptin is known to be associated with fat mass.5 In our T
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sensitivity analyses, the inﬂuence of BMI on leptin is clearly seen,
especially for the upper percentiles.
In our sample, adiponectin and leptin levels were slightly higher
in girls than in boys, which is in accordance with the ﬁndings in
children3,19 and in adults,4 reporting higher leptin levels in females
than in males.
There are some studies in healthy children on the national
level,8–10,20 but their comparability with our results is limited
mostly because of either a different age distribution of the sample
or due to incomparable laboratory analyses. Pre-analytical (for
example, serum vs plasma) and analytical factors (laboratory
method) can signiﬁcantly affect measured concentrations of leptin
and adiponectin. Concerning leptin, the ﬁrst main problem is that
laboratory methods may not be comparable. Enzyme-linked
immunosorbent assay demonstrates a wider leptin range than
radio immunoassay.9,16 Plasma concentrations of hormones are
generally higher than serum concentrations, partly due to the
removal of ﬁbrinogens in the serum.21 In addition, not only total,
but also either free or bound leptin concentrations have been
reported. L’Allemand et al.,10 for instance, speciﬁcally measured
free leptin. In a Greek study,9 the enzyme-linked immunosorbent
assay method was used to examine the serum leptin concentra-
tion of 294 children (154 boys). The mean age (± s.d.) of the
children was 9.3 ( ±1.8) years, and thus the average age is 3 years
higher than in our study. Another Greek study8 reported total
leptin levels of healthy, non-obese children, but it cannot be
compared with our results, because plasma leptin levels were
measured and the mean age of the children was higher than in
our cohort (mean age ± s.d.: 10.5 ± 1.5 vs 6.2 ± 1.7 years).
A paper by Venner et al.11 reviewed studies reporting leptin
reference ranges in prepubertal children. Their conclusion was
that only limited articles investigating leptin levels in children are
available in contrast to the numerous publications in human
adults. Their opinion was that one should be cautious referring to
published leptin values and means because of the dependency of
leptin levels on age and sex8,22 and the pre-analytical and
analytical sources of variation. As it is very difﬁcult to interpret
individual leptin values, there is a need to establish reference
values for leptin concentrations in prepubertal children.
With respect to adiponectin, most previous studies cannot be
compared with our results due to different age ranges of children
in these studies and the IDEFICS sample, considering the fact that
adiponectin levels change with age. There is only one Mexican
cross-sectional study19 that investigated 190 school-age children
classiﬁed as obese and 196 children classiﬁed as eutrophic. A
signiﬁcant difference (Po0.001) was found between eutrophic
and obese children with respect to anthropometric and metabolic
measurements. The mean adiponectin concentration in the
Mexican study was 15.5 μgml− 1 in normal-weight children (mean
age± s.d.: 9.4 ± 1.8 years), whereas in our cohort, that is on
average, 3 years younger, it was 11.4 μgml− 1 (mean age ± s.d.:
6.2 ± 1.7 years). Difference in adiponectin concentrations between
the two studies further supports the age dependency of
adiponectin.
According to our results, adiponectin percentiles show a
negative age trend and leptin levels above the 50th percentile
generally show a positive trend with age in both sexes. It is known
that obese individuals have lower adiponectin and higher leptin
levels compared with normal-weight individuals.20 The leptin
levels reﬂect changes in body fat content as the main site of leptin
production is the white adipose tissue. Changes in the investi-
gated hormone levels over age in the IDEFICS sample may reﬂect
the age-related changes in body composition (see Nagy et al.,23
this issue), that is, the increase in percent body fat. The
development of the hormone levels over age were reported by
others previously. Murphy et al.20 showed an age-dependant
increase of leptin and a decrease of adiponectin in British children
between the ages of 5 and 8 years. A Spanish study22 examiningT
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Figure 2. Smoothed percentile curves for adiponectin (μgml− 1) in girls and boys by age among normal-weight children aged 3.0–8.9 years
modelled by GAMLSS.
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Figure 3. Smoothed percentile curves for leptin (ngml− 1) in girls and boys by age among normal-weight children aged 3.0–8.9 years
modelled by GAMLSS.
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Figure 4. Smoothed percentile curves (3rd, 50th and 97th percentile) for adiponectin (μgml− 1) according to BMI categories among children
aged 2.0–9.9 years modelled by GAMLSS.
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789 normal-weight children found that the leptin levels rose from
5 to 15 years of age in parallel with total body weight.
In summary, according to our knowledge, the presented age-
and sex-speciﬁc percentiles of leptin and adiponectin are the ﬁrst
ones based on a European multinational non-clinical children’s
population, which is the most important strength of our study. In
addition, the applied statistical modelling was based on most
recent, advanced methodology.
There might be possible selection effects due to the construc-
tion of the obesity case–control study. Not all countries are
included in the case–control study; Cyprus had to be excluded
because they did not collect venous blood, and other countries,
for example, Italy (30%), Germany (21%) and Hungary (20%) are
overrepresented and Belgium (1%) and Sweden (7%) are under-
represented, remaining Estonia (11%) and Spain (10%). Despite
the fact that Southern Europe is somewhat overrepresented and
Western Europe is underrepresented, we have a good coverage of
Central, Northern and Eastern Europe compared with the
proportion of population living in these areas. Furthermore, our
analysis group does not differ from the IDEFICS baseline
population with respect to the age of parents, birth weight and
months of breastfeeding. In addition, our analysis group also
shows the same age distribution and only a slightly different sex
distribution (53% girls in our analysis group compared with 49% in
the study population). But families of children in the analysis
group show on average a lower income level (71% have an ISCED
level of 4 or lower versus 60% in the IDEFICS baseline survey) and
lower level of education (70% have a medium or lower income
level versus 64% in the IDEFICS baseline survey). The main
limitation of our results is the relatively small number of normal-
weight children. We applied different strategies as weighted
GAMLSS regression and bootstrap strategies to compensate for
the selection effect of obese and overweight children in the
nested case–control study. However, none of the approaches
could diminish the strong association of BMI on hormone levels,
especially on leptin. Therefore, we restricted the analysis to
normal-weight children only. The small sample size might have an
inﬂuence on the reliability of the curves. For this reason,
these ﬁndings should be used with care in clinical practise
and should rather be used as support for diagnosis than as a
decision tool.
CONCLUSION
The reference values presented for leptin and adiponectin in
mostly prepubertal, normal-weight children are the ﬁrst ones that
are based on a multinational non-clinical children cohort study.
These percentile values and curves have have an important role in
clinical practise and in epidemiological studies, because these
hormones are frequently measured in centres dealing with
endocrinology, diabetes and obesity, but the interpretation of
the individual values is hampered by the lack of valid reference
values. We hope that the percentiles presented here will help to
overcome this problem.
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